Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
LETTERS TO THE EDITOR

First Report of OXA-23-Mediated Carbapenem Resistance in Sequence Type 2 Multidrug-Resistant Acinetobacter baumannii Associated with Urinary Tract Infection in a Cat

Constança Pomba, Andrea Endimiani, Alexandra Rossano, Dolores Saial, Natacha Couto, Vincent Perreten
Constança Pomba
aLaboratory of Antimicrobial and Biocide Resistance, CIISA, Faculdade de Medicina Veterinária, Universidade de Lisboa (FMV-UL), Lisbon, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Endimiani
bInstitute for Infectious Diseases, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra Rossano
cInstitute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dolores Saial
aLaboratory of Antimicrobial and Biocide Resistance, CIISA, Faculdade de Medicina Veterinária, Universidade de Lisboa (FMV-UL), Lisbon, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natacha Couto
aLaboratory of Antimicrobial and Biocide Resistance, CIISA, Faculdade de Medicina Veterinária, Universidade de Lisboa (FMV-UL), Lisbon, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Perreten
cInstitute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.02527-13
  • Article
  • Info & Metrics
  • PDF
Loading

LETTER

Carbapenem resistance in multidrug-resistant Acinetobacter baumannii has been challenging human medicine (1, 2) and has also emerged in Acinetobacter spp. from animals; it is associated with the expression of OXA-23 in cattle and horses and NDM-1 in a porcine isolate (3–5). Yet, carbapenem resistance in A. baumannii from pets has been related only to overexpression of intrinsic genes (6). Here, we describe a multidrug-resistant A. baumannii isolate producing OXA-23 in a urinary tract infection (UTI) in a cat.

In 2009, a 3-year-old outdoor cat was presented with dysuria and hematuria at the Teaching Hospital of the FMV-UL. Aseptic urine culture revealed a significant A. baumannii bacteriuria; no other pathogens were found. The isolate was studied after the owner and the FMV-UL Ethics and Animal Welfare Committee gave approval. The cat had a 1.5-year history of skin and soft tissue infections, for which multiple courses of amoxicillin-clavulanate were prescribed. The cat was discharged before the culture result was available with an amoxicillin-clavulanate treatment per os for 20 days. We attempted to contact the owner without success. The animal was brought to the hospital 1 year later due to a hind limb trauma and had inexplicably recovered from the UTI.

The isolate (FMV6475/09) was identified using matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) analysis (Bruker Daltonik). MICs were determined by broth microdilution using the Sensititre ESB1F and EUMVS2 plates (Trek Diagnostic Systems) according to CLSI guidelines (7). The antibiotic resistance genes were detected using the version 08 AMR-ve microarray (Alere Technologies), an update of Card et al. (8). PCRs were performed for several acquired carbapenemase genes (9), for ISAba1 upstream of the intrinsic carbapenemase genes blaOXA-51-like and blaADC, and for sequences upstream and downstream of blaOXA-23 using specific primers (9–11) as well as a primer annealing at the 3′ end of ISAba1 (ISAba1-3′-R, 5′-TCACAGAACCCTTATCCTATC). Mutations in the quinolone resistance-determining region of gyrA and parC were detected as described previously (6). Multilocus sequence typing (MLST) was according to the recommendations given by the A. baumannii MLST database (http://www.pasteur.fr/recherche/genopole/PF8/mlst/Abaumannii.html). Conjugation was performed using A. baumannii BM4547 (kindly provided by L. Poirel and P. Nordmann) as the recipient and 1 μg/ml imipenem in the selective plates.

Strain FMV6475/09 was susceptible to gentamicin (MIC, 4 μg/ml), kanamycin (MIC, ≤4 μg/ml), and colistin (MIC, ≤2 μg/ml). The high MICs of meropenem, imipenem (MIC, >8 μg/ml), ceftazidime, cefepime, cefpodoxime, cefotaxime, ceftriaxone (MIC, >16 μg/ml), piperacillin-tazobactam, cefotaxime-clavulanic acid (MICs, >64, >4 μg/ml) and ceftazidime-clavulanic acid (MICs, 64, 4 μg/ml) were associated with the production of OXA-23 (1). The strain also contained ISAba1 upstream of blaADC, which enhances expression of the chromosomally encoded ADC cephalosporinase (12). Additional resistances were attributed to sul2 (sulfamethoxazole MIC, >1,024 μg/ml), tet(B) (tetracycline MIC, >64 μg/ml), strA, and strB (streptomycin MIC, >128 μg/ml) and to mutations in gyrA (Ser83Leu) and parC (Ser80Leu) (ciprofloxacin MIC, >8 μg/ml). Resistance to chloramphenicol and trimethoprim (MIC, >64 μg/ml) could not be attributed to the genes catA1, catIII, catB3-like, catB8, cmlA, or floR and dfrA1, dfrA7, dfrA12, dfrA13, dfrA14, dfrA17, or dfrA19, respectively. The blaOXA-23 gene was localized on the chromosome by DNA-DNA hybridization and could not be transferred by conjugation. It was flanked by two copies of intact ISAba1, and sequences of this region (EMBL accession no. HG797027) indicated its location on transposon Tn2006 and not on Tn2008, as has been found in cattle and horses (3, 4). Strain FMV6475/09 belonged to sequence type 2, which has been associated with European clone II. In the same time frame, this worldwide-disseminated clone (2) also containing blaOXA-23 on Tn2006 was endemic in Portuguese hospitals (13, 14), suggesting a possible human-to-animal transmission.

This is the first report of an OXA-23 carbapenem-hydrolyzing enzyme in A. baumannii from an infection in a pet. Companion animals may harbor carbapenemase-producing bacteria, which represents an additional veterinary and public health hazard.

  • Copyright © 2014, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Poirel L,
    2. Nordmann P
    . 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826–836. doi:10.1111/j.1469-0691.2006.01456.x.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Mugnier PD,
    2. Poirel L,
    3. Naas T,
    4. Nordmann P
    . 2010. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 16:35–40. doi:10.3201/eid1601.090852.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Poirel L,
    2. Berçot B,
    3. Millemann Y,
    4. Bonnin RA,
    5. Pannaux G,
    6. Nordmann P
    . 2012. Carbapenemase-producing Acinetobacter spp. in cattle, France. Emerg. Infect. Dis. 18:523–525. doi:10.3201/eid1803.111330.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Smet A,
    2. Boyen F,
    3. Pasmans F,
    4. Butaye P,
    5. Martens A,
    6. Nemec A,
    7. Deschaght P,
    8. Vaneechoutte M,
    9. Haesebrouck FJ
    . 2012. OXA-23-producing Acinetobacter species from horses: a public health hazard? J. Antimicrob. Chemother. 67:3009–3010. doi:10.1093/jac/dks311.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Zhang WJ,
    2. Lu Z,
    3. Schwarz S,
    4. Zhang RM,
    5. Wang XM,
    6. Si W,
    7. Yu S,
    8. Chen L,
    9. Liu S
    . 2013. Complete sequence of the blaNDM-1-carrying plasmid pNDM-AB from Acinetobacter baumannii of food animal origin. J. Antimicrob. Chemother. 68:1681–1682. doi:10.1093/jac/dkt066.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Endimiani A,
    2. Hujer KM,
    3. Hujer AM,
    4. Bertschy I,
    5. Rossano A,
    6. Koch C,
    7. Gerber V,
    8. Francey T,
    9. Bonomo RA,
    10. Perreten V
    . 2011. Acinetobacter baumannii isolates from pets and horses in Switzerland: molecular characterization and clinical data. J. Antimicrob. Chemother. 66:2248–2254. doi:10.1093/jac/dkr289.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. CLSI document M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.
  8. 8.↵
    1. Card R,
    2. Zhang J,
    3. Das P,
    4. Cook C,
    5. Woodford N,
    6. Anjum MF
    . 2013. Evaluation of an expanded microarray for detecting antibiotic resistance genes in a broad range of Gram-negative bacterial pathogens. Antimicrob. Agents Chemother. 57:458–465. doi:10.1128/AAC.01223-12.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Hujer KM,
    2. Hujer AM,
    3. Hulten EA,
    4. Bajaksouzian S,
    5. Adams JM,
    6. Donskey CJ,
    7. Ecker DJ,
    8. Massire C,
    9. Eshoo MW,
    10. Sampath R,
    11. Thomson JM,
    12. Rather PN,
    13. Craft DW,
    14. Fishbain JT,
    15. Ewell AJ,
    16. Jacobs MR,
    17. Paterson DL,
    18. Bonomo RA
    . 2006. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob. Agents Chemother. 50:4114–4123. doi:10.1128/AAC.00778-06.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Bonnin RA,
    2. Rotimi VO,
    3. Al Hubail M,
    4. Gasiorowski E,
    5. Al Sweih N,
    6. Nordmann P,
    7. Poirel L
    . 2013. Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait. Antimicrob. Agents Chemother. 57:183–188. doi:10.1128/AAC.01384-12.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Corvec S,
    2. Poirel L,
    3. Naas T,
    4. Drugeon H,
    5. Nordmann P
    . 2007. Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:1530–1533. doi:10.1128/AAC.01132-06.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Héritier C,
    2. Poirel L,
    3. Nordmann P
    . 2006. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin. Microbiol. Infect. 12:123–130. doi:10.1111/j.1469-0691.2005.01320.x.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Grosso F,
    2. Quinteira S,
    3. Peixe L
    . 2011. Understanding the dynamics of imipenem resistant Acinetobacter baumannii lineages within Portugal. Clin. Microbiol. Infect. 17:1275–1279. doi:10.1111/j.1469-0691.2011.03469.x.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Manageiro V,
    2. Jones-Dias D,
    3. Ferreira E,
    4. Louro D,
    5. Antimicrobial Resistance Surveillance Program in Portugal,
    6. Caniça M
    . 2012. Genetic diversity and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from Portugal and the dissemination of ST118. Int. J. Antimicrob. Agents. 40:398–403. doi:10.1016/j.ijantimicag.2012.06.013.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Download PDF
Citation Tools
First Report of OXA-23-Mediated Carbapenem Resistance in Sequence Type 2 Multidrug-Resistant Acinetobacter baumannii Associated with Urinary Tract Infection in a Cat
Constança Pomba, Andrea Endimiani, Alexandra Rossano, Dolores Saial, Natacha Couto, Vincent Perreten
Antimicrobial Agents and Chemotherapy Jan 2014, 58 (2) 1267-1268; DOI: 10.1128/AAC.02527-13

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
First Report of OXA-23-Mediated Carbapenem Resistance in Sequence Type 2 Multidrug-Resistant Acinetobacter baumannii Associated with Urinary Tract Infection in a Cat
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
First Report of OXA-23-Mediated Carbapenem Resistance in Sequence Type 2 Multidrug-Resistant Acinetobacter baumannii Associated with Urinary Tract Infection in a Cat
Constança Pomba, Andrea Endimiani, Alexandra Rossano, Dolores Saial, Natacha Couto, Vincent Perreten
Antimicrobial Agents and Chemotherapy Jan 2014, 58 (2) 1267-1268; DOI: 10.1128/AAC.02527-13
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596